⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IPHA News
Innate Pharma S.A. ADS
Innate Pharma to Participate in a Bladder Cancer Panel at the BTIG Virtual Biotechnology Conference
businesswire.com
IPHA
Innate Pharma participera à un panel de discussion sur le cancer de la vessie lors de la BTIG Virtual Biotechnology Conference
businesswire.com
IPHA
Innate Pharma Announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-drug Conjugate (ADC)
businesswire.com
IPHA
Innate Pharma annonce la finalisation du recrutement de l’escalade de dose dans l’étude de phase 1 évaluant IPH4502, un nouvel anticorps conjugué-médicament (ADC) ciblant la Nectine-4 et utilisant l’exatécan
businesswire.com
IPHA
Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight
globenewswire.com
IMVT
ROIV
MRK
NVS
REGN
UCB
JNJ
ARGX
AMGN
VIR
IPHA
ARWR
APLS
CABA
A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company
prnewswire.com
GTBP
IPHA
INKT
IPSC
Synovial Sarcoma Clinical Trial Pipeline Accelerates as 15+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
KURA
BMY
IPHA
MRK
MNPR
JAZZ
MOLN
LLY
GSK
AGEN
PFE
Outcome of Innate Pharma’s 2026 Annual General Meeting
businesswire.com
IPHA
Résultats de l'Assemblée Générale mixte d'Innate Pharma du 21 Mai 2026
businesswire.com
IPHA
Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
globenewswire.com
SNGX
IPHA
BMY
NKTX
AZN
MRK
TAK
NVS
GMAB
ABBV
BIIB
CRSP
INCY
ALKS
PFE
REGN
GILD
AMGN